Cypress Wealth Services
GSK icon

Cypress Wealth Services’s GSK GSK Stock Holding History

Cypress Wealth Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$522K Sell
11,202
-448
-4% -$22.9K 0.06% 229
2026
Q2 		$611K Sell
11,650
-122
-1% -$6.45K 0.07% 201
2026
Q1 		$650K Sell
11,772
-21
-0.2% -$1.14K 0.09% 177
2025
Q4 		$578K Buy
11,793
+151
+1% +$7.04K 0.08% 194
2025
Q3 		$502K Buy
11,642
+53
+0.5% +$2.07K 0.08% 180
2025
Q2 		$445K Buy
11,589
+145
+1% +$5.54K 0.08% 188
2025
Q1 		$443K Sell
11,444
-522
-4% -$19.1K 0.09% 166
2024
Q4 		$405K Buy
11,966
+2,301
+24% +$82.8K 0.08% 171
2024
Q3 		$395K Buy
9,665
+105
+1% +$4.3K 0.08% 177
2024
Q2 		$368K Buy
9,560
+130
+1% +$5.47K 0.08% 174
2024
Q1 		$404K Hold
9,430
– – 0.09% 165
2023
Q4 		$349K Sell
9,430
-208
-2% -$7.47K 0.09% 174
2023
Q3 		$349K Buy
+9,638
New +$342K 0.1% 170

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Letko, Brosseau & Associates
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.9B AUM 29.83% 1-Year Est. Return
Miller Howard Investments
Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Cypress Wealth Services's GSK Position: Q3 2026 in Review

Cypress Wealth Services reduced its GSK (GSK) stake by 3.8% in Q3 2026, selling an estimated $22.9K and leaving 11,202 shares worth $522K. The position accounts for 0.06% of the portfolio, ranked #229.

Cypress Wealth Services first reported a position in GSK in Q3 2023 and has held it in 13 quarters since. The position peaked at $650K in Q1 2026. 558 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Cypress Wealth Services held 11,202 shares of GSK worth $522K as of Q3 2026.
  • Cypress Wealth Services sold 448 GSK shares in Q3 2026, an estimated $22.9K.
  • GSK made up 0.06% of Cypress Wealth Services's portfolio in Q3 2026, its #229 holding.
  • Cypress Wealth Services first reported a position in GSK in Q3 2023 and has held it in 13 quarters since.
  • Cypress Wealth Services's GSK position peaked at $650K in Q1 2026.
  • 558 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Cypress Wealth Services's 13F filing for Q3 2026, filed 21 Oct 2026.